Palisade Bio, Inc. Common Stock (NASDAQ: PALI) last traded at $2.10, up 1.94% on the session. The quote above updates while this page is open; the figures below are drawn from Palisade Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Palisade Bio, Inc. Common Stock trades on NASDAQ under the ticker PALI. Its market capitalisation is $365.97 million.
Valuation measures for Palisade Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $365.97M |
|---|---|
| Enterprise value | $246.36M |
| Price / sales | 731.94 |
| Price / book | 3.01 |
| Beta | 1.27 |
Trailing-twelve-month figures tagged in Palisade Bio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $500.0K |
|---|---|
| Net income (TTM) | -$31.94M |
| Operating margin | -7069.80% |
| Return on equity | -26.24% |
| Cash | $125.17M |
Range and volume for PALI over the past 52 weeks.
| 52-week high | $2.86 |
|---|---|
| 52-week low | $0.530 |
| Volume | 1.07M |
| Average volume | 3.02M |
| Previous close | $2.06 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.